Ceva Santé Animale is pleased to announce a series of video interviews covering several aspects of Gumboro disease control, with experts from around the world.
Ceva have contributed to the control of Gumboro disease for several years, due to the expertise of our team, but as well also with the products that have been developed for the poultry industry, such as Transmune.
Ceva Santé Animale has protected over 200 billion broilers against Gumboro disease since 2006 with our products and has acquired great expertise and knowledge along the way.
In the different episodes we will learn from the experts several important aspects for the proper control of Gumboro disease. Several challenges will be discussed such as: how it can be tackled, how to diagnosis it, what the effects are on the farms and on the performance of broiler flocks.
As demands can change along the way, the series will also cover the epidemiology of the Gumboro virus and how controlling the disease allows the poultry producer to achieve the best results.
The interview series will provide a tour around the world capturing the different challenges, different situations and realities in the eyes of the experts.
We hope you will enjoy this video series.
Stay tuned for the videos!!
"*" indicates required fields
Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.
Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (18) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.